salivary gland cancers
Showing 1 - 25 of 7,537
Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)
Not yet recruiting
- Gland
- Salivary Gland Cancers
- Sacituzumab Govitecan
-
Houston, TexasM D Anderson Cancer Center
May 22, 2023
GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY
Not yet recruiting
- Salivary Gland Cancer
- Observation
- (no location specified)
Oct 13, 2023
Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)
Recruiting
- Adenoid Cystic Carcinoma
- Salivary Gland Cancer
-
Miami, Florida
- +7 more
Oct 26, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare
Recruiting
- Salivary Gland Tumor
- Rare Malignant Neoplasm
- 68-Ga PSMA PET scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 11, 2022
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)
Recruiting
- Salivary Gland Cancer
- +3 more
- Selinexor
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 18, 2022
Salivary Glands Tumors Trial in Milan (Abiraterone acetate)
Completed
- Salivary Glands Tumors
- Abiraterone acetate
-
Milan, Lombardy, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Mar 1, 2021
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
European Reference Network on Rare Adult Solid Cancers
Recruiting
- Head and Neck Cancer
- +4 more
- observation
-
Brno, Czechia
- +10 more
Aug 1, 2022
Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,
Recruiting
- Salivary Gland Cancer
- HER2 Gene Mutation
- Ado-trastuzumab (T) emtansine (T-DM1)
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 2, 2023
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Immune Biomarker Study for Salivary Gland Carcinoma
Not yet recruiting
- Salivary Gland Tumor
- Benign Salivary Gland Tumor
- Sampling
-
Erlangen, Bavaria, Germany
- +1 more
Sep 21, 2023
Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)
Recruiting
- Solid Tumor
- +10 more
-
Belfast, United Kingdom
- +25 more
Mar 28, 2023
Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)
Not yet recruiting
- Advanced Salivary Gland Carcinoma
- SHR-A1811
- +2 more
-
Shanghai, ChinaDongmei Ji
Jun 21, 2023
Salivary Gland Tumor, Diagnosis Trial in Thessaloníki (Fine Needle Aspiration, Histologic Examination)
Completed
- Salivary Gland Tumor
- Diagnosis
- Fine Needle Aspiration
- Histologic Examination
-
Thessaloníki, GreeceAristotle University
Sep 11, 2023
Recurrent Salivary Gland Infections in Covid-19 Trial in Banha
Active, not recruiting
- Recurrent Salivary Gland Infections in Covid-19
-
Banhā, EgyptBenha university hospitals
Jun 2, 2023
Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant
Completed
- Salivary Gland Cancer
- Salivary Gland Neoplasms
- Surgical intervention with or without postoperative adjuvant therapy
-
Novi Sad, SerbiaClinic for maxillofacial surgery Clinical center of Vojvodina
May 22, 2022
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48)
- +3 more
- (no location specified)
Jun 9, 2023
Head Neck Cancers - Salivary Gland Trial in Shanghai (Surufatinib)
Recruiting
- Head and Neck Cancers - Salivary Gland
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 28, 2021
Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in
Recruiting
- Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
- +2 more
- Vedolizumab
- +5 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2023
Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)
Recruiting
- Salivary Gland Cancer
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 15, 2021
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial
Recruiting
- Metastatic Salivary Gland Carcinoma
- +4 more
- Docetaxel
- +3 more
-
New York, New YorkMemorial Sloane Kettering Cancer Center
Jan 11, 2023